Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Oren Pasvolsky, Tamar Berger, Karyn Revital Geiger, Amit Akirov, Elias Bshara, Pia Raanani, Anat Gafter-Gvili, Tzippy Shochat, Uri Rozovski & Ronit Gurion. (2022) Infectious complications and long-term outcomes in patients with diffuse large B-Cell lymphoma and diabetes mellitus. Leukemia & Lymphoma 63:14, pages 3378-3384.
Read now
Read now
Sushanth Gouni, Paolo Strati, Gokce Toruner, Akanksha Aradhya, Ralf Landgraf, Daniel Bilbao, Francisco Vega & Nitin Kumar Agarwal. (2022) Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma. Leukemia & Lymphoma 63:6, pages 1302-1313.
Read now
Read now
Yaser Alkhatib, Zaid Abdel Rahman & Philip Kuriakose. (2017) Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study. Leukemia & Lymphoma 58:5, pages 1130-1134.
Read now
Read now
Articles from other publishers (19)
Zikun Wang, Lawrence S. Phillips, Thomas E. Rohan, Gloria Y. F. Ho, Aladdin H. Shadyab, Aurelian Bidulescu, Charles N. Rudick, Kathy Pan, Zhongxue Chen & Juhua Luo. (2022)
Diabetes, metformin use and risk of non‐
Hodgkin's
lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative
. International Journal of Cancer 152:8, pages 1556-1569.
Crossref
Crossref
Yi Zhang, Fang Zhou, Jiaheng Guan, Lukun Zhou & Baoan Chen. (2023) Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review. Biomolecules 13:2, pages 250.
Crossref
Crossref
Yanbing Li, Huijie Zhou & Liqun Zou. (2022) Influence of Statins on the Survival Outcomes of Patients with Diffuse Large B Cell Lymphoma: A Systematic Review and Meta-Analysis. International Journal of Clinical Practice 2022, pages 1-9.
Crossref
Crossref
Zhen Han, Hong Xu, Meiqing Zhao, Fanjing Jing, Hongwei Xue & Shuxin Xiao. (2022) Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies. Clinical Lymphoma Myeloma and Leukemia 22:2, pages e77-e88.
Crossref
Crossref
Liam Smyth, Danielle N. Blunt & Matthew C. Cheung. (2021) Statins in mature B‐cell lymphomas and leukaemias. British Journal of Haematology 195:4, pages 490-492.
Crossref
Crossref
Elsa Brånvall, Sara Ekberg, Sandra Eloranta, Tove Wästerlid, Brenda M. Birmann & Karin E. Smedby. (2021) Statin use and survival in 16 098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era. British Journal of Haematology 195:4, pages 552-560.
Crossref
Crossref
Xiang-Nan Jiang, Yan Zhang, Wei-Ge Wang, Dong Sheng, Xiao-Yan Zhou & Xiao-Qiu Li. (2021) Alteration of Cholesterol Metabolism by Metformin Is Associated With Improved Outcome in Type II Diabetic Patients With Diffuse Large B-Cell Lymphoma. Frontiers in Oncology 11.
Crossref
Crossref
Ademar Dantas da Cunha Júnior, Dalila Luciola Zanette, Fernando Vieira Pericole, Sara Teresinha Olalla Saad & José Barreto Campello Carvalheira. (2021) Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?. Advances in Hematology 2021, pages 1-7.
Crossref
Crossref
Ali Fatehi Hassanabad. (2020) Is There a Role for Statins and Metformin in Cancer Therapy?. American Journal of Clinical Oncology 43:12, pages 833-835.
Crossref
Crossref
Liam Smyth, Danielle N. Blunt, Evgenia Gatov, Chenthila Nagamuthu, Ruth Croxford, Lee Mozessohn & Matthew C. Cheung. (2020) Statin and cyclooxygenase‐2 inhibitors improve survival in newly diagnosed diffuse large B‐cell lymphoma: a large population‐based study of 4913 subjects. British Journal of Haematology 191:3, pages 396-404.
Crossref
Crossref
Yucai Wang, Matthew J. Maurer, Melissa C. Larson, Cristine Allmer, Andrew L. Feldman, N. Nora Bennani, Carrie A. Thompson, Luis F. Porrata, Thomas M. Habermann, Thomas E. Witzig, Stephen M. Ansell, Susan L. Slager, Grzegorz S. Nowakowski & James R. Cerhan. (2019) Impact of metformin use on the outcomes of newly diagnosed diffuse large B‐cell lymphoma and follicular lymphoma. British Journal of Haematology 186:6, pages 820-828.
Crossref
Crossref
James R CerhanBrian K LinkThomas M HabermannMatthew J MaurerAndrew L Feldman, Sergei I Syrbu, Carrie A ThompsonUmar FarooqAnne J NovakSusan L SlagerCristine AllmerJulianne J LundeWilliam R Macon, David J InwardsPatrick B JohnstonIvana NM MicallefGrzegorz S NowakowskiStephen M AnsellNeil E KayGeorge J WeinerThomas E Witzig. (2017) Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study. International Journal of Epidemiology 46:6, pages 1753-1754i.
Crossref
Crossref
Xibiao Ye, Ayat Mneina, James B. Johnston & Salaheddin M. Mahmud. (2017) Associations between statin use and non-Hodgkin lymphoma (NHL) risk and survival: a meta-analysis. Hematological Oncology 35:2, pages 206-214.
Crossref
Crossref
Ping-Ting Zhou, Bo Li, Fu-Rao Liu, Mei-Chao Zhang, Qian Wang, Yan-Yan Li, Ci Xu, Yuan-Hua Liu, Yuan Yao & Dong Li. (2017) Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Oncotarget 8:15, pages 25242-25250.
Crossref
Crossref
R Agca, S C Heslinga, S Rollefstad, M Heslinga, I B McInnes, M J L Peters, T K Kvien, M Dougados, H Radner, F Atzeni, J Primdahl, A Södergren, S Wallberg Jonsson, J van Rompay, C Zabalan, T R Pedersen, L Jacobsson, K de Vlam, M A Gonzalez-Gay, A G Semb, G D Kitas, Y M Smulders, Z Szekanecz, N Sattar, D P M Symmons & M T Nurmohamed. (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Annals of the Rheumatic Diseases 76:1, pages 17-28.
Crossref
Crossref
K. Heelan, S. Knowles, S. Walsh & N.H. Shear. (2014) Effect of concomitant statin use on rituximab treatment for pemphigus and pemphigoid disorders: a case-based review. Journal of the European Academy of Dermatology and Venereology 28:4, pages 520-522.
Crossref
Crossref
Ming Yin, Jie Zhou, Edward J. Gorak & Fahd Quddus. (2013) Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis. The Oncologist 18:12, pages 1248-1255.
Crossref
Crossref
Yumi Nozaki, Toru Mitsumori, Takeo Yamamoto, Ichiro Kawashima, Yuki Shobu, Satoshi Hamanaka, Kei Nakajima, Norio Komatsu & Keita Kirito. (2013) Rituximab activates Syk and AKT in CD20-positive B cell lymphoma cells dependent on cell membrane cholesterol levels. Experimental Hematology 41:8, pages 687-696.e1.
Crossref
Crossref
Aaron E. Hoffman, Kathryn Demanelis, Alan Fu, Tongzhang Zheng & Yong Zhu. (2013) Association of AMP-Activated Protein Kinase with Risk and Progression of Non–Hodgkin Lymphoma. Cancer Epidemiology, Biomarkers & Prevention 22:4, pages 736-744.
Crossref
Crossref